Position in GMED
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,254,471
-$22,651 QoQ
Shares Held
28,534
+8.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#213
of 597 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GMED Over Time
Shares Held
Position Value (USD)
Derivatives in GMED
reported options exposure · as of Sep 30, 2025CallValue
$372,255
CallShares
6,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026VELA Investment Management, LLC holds $18,445,783 across 6 Medical Devices names. GMED ranks #5 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
54,892 | $4,980,900 | |
| 2 | BRKR |
Bruker Corp
|
77,459 | $4,661,482 | |
| 3 | SIBN |
SI-BONE, Inc.
|
201,094 | $3,281,854 | |
| 4 | PRCT |
PROCEPT BioRobotics Corp
|
117,894 | $2,662,046 | |
| 5 | GMED |
Globus Medical Inc
This page
|
28,534 | $2,254,471 | |
| 6 | MDT |
Medtronic plc
|
7,734 | $605,030 |
All Filings in GMED
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,254,471 | 28,534 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,277,122 | 26,429 | Shares | Sole | 2026-08-27 | |
| 2025-12-31 | $2,270,409 | 26,004 | Shares | Sole | 2026-08-27 | |
| 2025-09-30 | $1,459,411 | 25,483 | Shares | Sole | 2025-10-30 | |
| 2025-09-30 | $372,255 | 6,500 | Call | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||